Yiwen Wang, PhD
Senior Biostatistician

Yiwen joined the QSU in January 2022. She has her PhD in Epidemiology from The Ohio State University. 


Clinical Area of Interest:

Oncology, Transplantation, Endocrinology

Methodology area of interest:

Survival analysis, machine learning methodologies, feature selections for high-dimensional omics data, causal inference

Selected Publications:

  • Wang, Y., Zhou, W., Wang, J., Karaesmen, E., Tang, H., McCarthy, P. L., Pasquini, M. C., Wang, Y., McReynolds, L. J., Katki, H. A., Machiela, M. J., Yeager, M., Pooler, L., Sheng, X., Haiman, C. A., Van Den Berg, D., Spellman, S. R., Wang, T., Kuxhausen, M., Chanock, S. J., … Sucheston-Campbell, L. E. (2021). Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT. Blood advances5(1), 66–70.
  • Unger, K., Mehta, K. Y., Kaur, P., Wang, Y., Menon, S. S., Jain, S. K., Moonjelly, R. A., Suman, S., Datta, K., Singh, R., Fogel, P., & Cheema, A. K. (2018). Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma. Oncotarget9(33), 23078–23090.